Real-world data (RWD) and real-world evidence (RWE) have been utilized not only for drug safety assessment but also for effectiveness evaluation for drug approval on a global basis and many cases of RWD/RWE utilization for regulatory purposes have been accumulated with more diversifications in terms of data sources, methodology and study region (Kajiyama et al., 2024;Asano et al., 2025;Bachinger et al., 2025;Innes et al., 2025). Scientific discussions toward international harmonization related to RWD/RWE In conclusion, this research topic reflects a field of RWD/RWE utilization in transition from merely using RWD to actively strengthening RWE for decision-making use. The five studies provide a multifaceted view of the current state and emerging
6 Authors
- TA
Takashi Ando
Department of Digital Health, Japan
- TH
Tomoaki Hasegawa
Department of Digital Health, Japan
- CI
Chieko Ishiguro
Laboratory of Clinical Epidemiology, Japan
- JK
Jun Komiyama
Department of Health Services Research, Japan
- TK
Toshiki Kuno
Cardiology Division, United States
- MI
Masao Iwagami
Department of Digital Health, Japan
3,749 views
2 Authors
- CI
Chieko Ishiguro
Laboratory of Clinical Epidemiology, Department of Data Science, Center for Clinical Sciences, Japan Institute for Health Security, Japan
- TN
Takahiro Nonaka
Department of Clinical Research Governance, The University of Tokyo Hospital, Graduate School of Medicine, The University of Tokyo, Japan
2,229 views
1 citations
17 Authors
- SS
Satoko Suzuki
Department of Education and Support for Regional Medicine (General and Kampo Medicine), Japan
- RA
Ryutaro Arita
Department of Education and Support for Regional Medicine (General and Kampo Medicine), Japan
- TO
Taku Obara
Department of Pharmaceutical Sciences, Japan
- TI
Tomofumi Ishikawa
Laboratory of Biomolecule and Pathophysiological Chemistry, Japan
- TK
Tadaharu Kunitoki
Division of Clinical Pharmacology and Therapeutics, Japan
- TS
Takamasa Sakai
Drug Informatics, Japan
- AN
Aoi Noda
Department of Pharmaceutical Sciences, Japan
- GS
Genki Shinoda
Division of Molecular Epidemiology, Japan
- MI
Mami Ishikuro
Division of Molecular Epidemiology, Japan
- MO
Masatsugu Orui
Division of Molecular Epidemiology, Japan
- SK
Shinichi Kuriyama
Division of Molecular Epidemiology, Japan
- MO
Minoru Ohsawa
Department of Education and Support for Regional Medicine (General and Kampo Medicine), Japan
- KH
Ken Haneda
Department of Education and Support for Regional Medicine (General and Kampo Medicine), Japan
- NM
Nariyasu Mano
Department of Pharmaceutical Sciences, Japan
- AK
Akiko Kikuchi
Department of Education and Support for Regional Medicine (General and Kampo Medicine), Japan
- ST
Shin Takayama
Department of Education and Support for Regional Medicine (General and Kampo Medicine), Japan
- TI
Tadashi Ishii
Department of Education and Support for Regional Medicine (General and Kampo Medicine), Japan
3,323 views
1 citations
7 Authors
- PZ
Pei Zhang
Shandong Engineering and Technology Research Center for Pediatric Drug Development, China
- QC
Qiong Chen
Department of Dermatology, China
- JL
Jiahui Lao
Center for Big Data Research in Health and Medicine, China
- JS
Juan Shi
Department of Clinical Pharmacy, China
- JC
Jia Cao
Center for Big Data Research in Health and Medicine, China
- XL
Xiao Li
Shandong Engineering and Technology Research Center for Pediatric Drug Development, China
- XH
Xin Huang
Shandong Engineering and Technology Research Center for Pediatric Drug Development, China
8 Authors
- HY
Hiroshi Yamazaki
Global Epidemiology, Japan
- KN
Ko Nakajo
Global Epidemiology, Japan
- NH
Naoki Hirose
Global Epidemiology, Japan
- LY
Li Yan
Global Epidemiology, China
- SY
Sun Yeop Lee
Global Epidemiology, Republic of Korea
- YZ
Yongjing Zhang
Global Epidemiology, China
- HQ
Hong Qiu
Global Epidemiology, United States
- CI
Chieko Ishiguro
Laboratory of Epidemiology Section, Japan
4,897 views
3 citations